Neutrophil/lymphocyte and platelet/lymphocyte ratios are not different among breast cancer subtypes

Asian Pacific Journal of Cancer Prevention

Volumn 18, Issue 8, 2017, Pages 2227-2231

  Yersal, Özlem ^a   Çetinkünar, Süleyman ^b   Aktimur, Recep ^a   Aziret, Mehmet ^c   Özdas, Sabri ^d   Erdem, Hasan ^b   Yildirim, Kadir ^c  

^a SAMSUN TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Adana Numune Training and Research Hospital   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

^d Adiyaman Training and Research Hospital   (Turkey)

Author keywords

Breast cancer; CerbB2; Estrogen receptor; Neutrophil lymphocyte ratio (NLR); Progesterone receptor

Indexed keywords

EID: 85028324007     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.22034/APJCP.2017.18.8.2227     Document Type: Article

References (22)

1. Azab B, Shah N, Radbel J, et al (2013). Pretreatment neutrophil/ lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol, 30, 432
2. Balkwill FR, Mantovani A (2012). Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol, 22, 33-40
3. Dirican A, Kucukzeybek BB, Alacacioglu A, et al (2015). Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?. Int J Clin Oncol, 20, 70-81
4. Faria SS, Fernandes PC, Silva MJB, et al(2016). The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience, 10, 702
5. Galdiero MR, Bonavita E, Barajon I, et al (2013). Tumor associated macrophages and neutrophils in cancer. Immunobiology, 218, 1402-10
6. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K (2013). Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer, 109, 401-7
7. Jia J, Zheng X, Chen Y, et al(2015). Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumour Biol, 36, 9319-25
8. Jia W, Wu J, Jia H, et al (2015). The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-to monocyte ratio for predicting the long-term survival of triple-negative breast cancer patients. PLoS One, 10, e0143061
9. Kim EY, Lee JW, Yoo HM, Park CH, Song KY (2015). The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer?. Ann Surg Oncol, 22, 4363-70
10. Koh YW, Lee HJ, Ahn JH, Lee JW, Gong G (2014). Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting. Tumour Biol, 35, 9823-30
11. Li MX, Liu XM, Zhang XF, et al (2014). Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer, 134, 2403-13
12. Liu Z, Zhang XS, Zhang S (2014). Breast tumor subgroups reveal diverse clinical prognostic power. Sci Rep, 4, 4002
13. Luen SJ, Loi S (2016). Immunotherapy in breast cancer: the subtype story. In Cancer Forum 40: [Internet]
14. Noh H, Eomm M, Han A (2013). Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer, 16, 55-9
15. Peng B, Wang YH, Liu YM, Ma LX (2015). Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis. Int J Clin Exp Med, 8, 3098-3106
16. Pistelli M, De Lisa M, Ballatore Z, et al (2015). Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients. BMC Cancer, 15, 95
17. Quail DF, Joyce JA (2013). Microenvironmental regulation of tumor progression and metastasis. Nat Med, 19, 1423-37
18. Stotz M, Gerger A, Eisner F et al (2013). Increased neutrophil lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21
19. Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8
20. Ulas A, Avci N, Kos T, et al(2015). Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?. J Buon, 20, 714-22
21. Yao M, Liu Y, Jin H, et al (2014). Prognostic value of preoperative inflammatory markers in Chinese patients with cancer. Onco Targets Ther, 7, 1743-52
22. Yersal O, Barutca S (2014). Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol, 5, 412-24